CLINICAL_TRIALS
trial_result
· 2021-06-01
Clinical Trial Update: Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication [Phase 4]
Summary
Phase 4 trial update evaluating vonoprazan as first-line treatment for Helicobacter pylori eradication, reporting on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN